Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Barrier Therapeutics (BTRX)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for BTRX as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
2.00M
LOW
EBITDA
►
-2.75M
AVG
Net Income
►
-8.39M
AVG
Revenue Growth
►
-35.1%
AVG
Operating Margin
►
-254.5%
AVG
Net Margin
►
-419.7%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-1.74
Current Ratio
►
0.123
VERY LOW
Quick Ratio
►
0.0566
VERY LOW
Interest Coverage Ratio
►
-1.54
AVG
Book Value Per Share
►
-4.69
Cash Per Share
►
0.0361
Loading...
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
VALUATION
Price to Earnings (P/E)
►
0
Price to Book (P/B)
►
0
Price to Sales (P/S)
►
0
Return on Assets (ROA)
►
-214.9%
VERY LOW
Return on Equity (ROE)
►
381.3%
VERY HIGH
EV/EBITDA
►
-0.00694
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0%
Held by insiders
32243.5%